The scientist’s investigation covers issues in Internal medicine, Irritable bowel syndrome, Gastroenterology, Immunology and Gut flora. Eamonn Martin Quigley combines subjects such as Placebo, Surgery and MEDLINE with his study of Internal medicine. His work deals with themes such as Inflammatory bowel disease, Intensive care medicine, Meta-analysis, Diarrhea and Abdominal pain, which intersect with Irritable bowel syndrome.
His Gastroenterology study combines topics in areas such as Epidemiology, Defecation, Motility, Esophagus and Electrodiagnosis. In his study, Malnutrition is inextricably linked to Secretion, which falls within the broad field of Immunology. As a part of the same scientific family, Eamonn Martin Quigley mostly works in the field of Gut flora, focusing on Microbiology and, on occasion, Bacteria.
His scientific interests lie mostly in Internal medicine, Gastroenterology, Irritable bowel syndrome, Disease and Intensive care medicine. His studies in Internal medicine integrate themes in fields like Placebo, Endocrinology and Surgery. His Gastroenterology research incorporates elements of Small intestine, Etiology and GERD.
Eamonn Martin Quigley has included themes like Inflammatory bowel disease, MEDLINE, Immunology and Bloating, Abdominal pain in his Irritable bowel syndrome study. His Immunology study combines topics from a wide range of disciplines, such as Microbiome and Probiotic. His study in Disease focuses on Nerd in particular.
Eamonn Martin Quigley mainly investigates Internal medicine, Irritable bowel syndrome, Gastroenterology, Microbiome and Disease. In his research, Adverse effect is intimately related to Placebo, which falls under the overarching field of Internal medicine. His Irritable bowel syndrome study integrates concerns from other disciplines, such as Interleukin, Cytokine, Synbiotics, MEDLINE and Randomized controlled trial.
Many of his research projects under Gastroenterology are closely connected to Capsule with Capsule, tying the diverse disciplines of science together. The concepts of his Microbiome study are interwoven with issues in Liver disease and Gut flora, Immunology. His research in Disease tackles topics such as Intensive care medicine which are related to areas like Small intestinal bacterial overgrowth, Epidemiology and Gastroparesis.
His primary areas of study are Internal medicine, Irritable bowel syndrome, Microbiome, Disease and Gastroenterology. His Internal medicine research integrates issues from Placebo and Eluxadoline. His Irritable bowel syndrome research includes elements of MEDLINE, Relative risk, Randomized controlled trial, Intensive care medicine and Meta-analysis.
The various areas that he examines in his Microbiome study include Liver disease, Gut flora, Immunology and Fecal bacteriotherapy. Eamonn Martin Quigley interconnects Prebiotic, Neuroscience, Gut microbiome and Bioinformatics in the investigation of issues within Disease. In general Gastroenterology, his work in Rome process is often linked to Economic shortage linking many areas of study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles
Liam O’Mahony;Jane McCarthy;Peter Kelly;George Hurley.
Guidelines for prevention of NSAID-related ulcer complications
Frank L Lanza;Francis K L Chan;Eamonn M M Quigley.
The American Journal of Gastroenterology (2009)
Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses.
Siobhain M. O'Mahony;Julian R. Marchesi;Julian R. Marchesi;Paul Scully;Caroline Codling.
Biological Psychiatry (2009)
Exercise and associated dietary extremes impact on gut microbial diversity
Siobhan F Clarke;Siobhan F Clarke;Eileen F Murphy;Orla O'Sullivan;Alice J Lucey.
Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
Peter J. Whorwell;Linda Altringer;Jorge Morel;Yvonne Bond.
The American Journal of Gastroenterology (2006)
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
Paul Moayyedi;Alexander Charles Ford;Nicholas J Talley;Filippo Cremonini.
Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models
E. F. Murphy;P. D. Cotter;P. D. Cotter;S. Healy;Tatiana M. Marques;Tatiana M. Marques.
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota
Ian B. Jeffery;Paul W. O'Toole;Lena Öhman;Marcus J. Claesson.
Irritable bowel syndrome
Paul Enck;Qasim Aziz;Giovanni Barbara;Adam D. Farmer.
Nature Reviews Disease Primers (2016)
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis
Alexander C Ford;Nicholas J Talley;Brennan M R Spiegel;Amy E Foxx-Orenstein.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: